Published
David G. Bostwick, MD, MBA, FCAP, Triopsy Medical, LLC, Orlando, Florida, discusses the potential of intratumoral immunotherapy in treating prostate cancer and other challenging malignancies. In this 19-minute presentation, Dr. Bostwick explores multiplex immunotherapy as a promising avenue for traditionally immunologically resistant cancers like prostate cancer. His presentation inspires optimism for advancing treatment strategies through innovative immune-based approaches.
- Category
- Oncology
Be the first to comment
Up Next
-
16:48
How Immunotherapy Is Changing Lung Cancer Treatment
-
17:45
Innovation Behind- Intratumoral Immunotherapy (Part 2)
-
05:17
POLARIX 5yr Update from Lymphoma ASH 2024
-
14:05
How Immunotherapy Controls Cancer | New Cancer Treatment | Immunotherapy Future of Cancer Treatment
-
07:18
This GADGET could improve your Penis: UPDATE 2024 | UroChannel
-
05:17
When Is Immunotherapy Given? Understanding Cancer Immunotherapy | Dr. Anup Toshniwal
-
12:36
Pacey-Cuff ULTRA 2024 Clinician Update
-
06:45
ctDNA-Guided Immunotherapy: A New Era of Gastric Cancer Recurrence Prevention
-
04:24
GU oncology update from ESMO 2024
-
06:58
Advanced Stage Cancer Recovery with Immunotherapy (CAM)| Real Patient Story at Cancer Healer Center
-
09:07
Cardiology for Beginners: Basics of Heart Sounds and Murmurs (with examples)
-
13:45
How to Become a Cardiologist | Cardiac Electrophysiologist
-
04:14
V 00592 Cardiology Fellowship Video Dr Vranian V5
-
05:17
Cardiology Fellowship at SIU Medicine
-
04:15
Cardiology Fellowship Program at Danbury Hospital
-
05:49
Practice Question: Cardiology #1, USMLE Step 1, COMLEX Level 1
-
04:07
Dr. Muhammed Raza on advice for Fellows interested in Interventional Cardiology
-
07:36
Congenital Heart Disease – Cardiology | Lecturio
-
05:18
Cardiology Fellowship at IU School of Medicine
-
04:36
What are different types of Cardiology Tests | SPS Hospitals
